Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1996
10/09/1996EP0736011A1 Anellated dihydropyridines and their use in the production of pharmaceutical preparations
10/09/1996EP0736009A1 N-oxides of 4-arylpiperazines and 4-arylpiperidines as antipsychotic drugs
10/09/1996EP0736008A1 Indole derivatives as anti-estrogens
10/09/1996EP0736007A1 Non-peptide tachykinin receptor antagonists
10/09/1996EP0736006A1 Phenylthiophenyl cycloalkenyl hydroxyureas as lipoxygenase inhibitors
10/09/1996EP0736005A1 Aminocarboxylic acid amides, process for preparing the same and their use as anti-arrhythmic agents
10/09/1996EP0736004A1 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceuticals
10/09/1996EP0735899A1 Synthetic oligomers having phosphonate internucleosidyl linkages of undefined chirality mixed with non-phosphonate internucleosidyl linkages
10/09/1996EP0735892A1 Laxative compositions containing bulk fiber and dioctyl sulfosuccinate
10/09/1996EP0735891A1 A 46 Kd HUMAN MILK FAT GLOBULE ANTIGEN
10/09/1996EP0735889A1 A novel tumor suppressor gene
10/09/1996EP0735888A1 Purine compositions and methods for administration
10/09/1996EP0735887A1 $i(IN UTERO) GENE THERAPY FOR FETUSES
10/09/1996EP0735885A1 Psoriasis treatment
10/09/1996EP0735884A1 Flunisolide aerosol formulations
10/09/1996EP0735883A1 Composition for a contraceptive comprising an estrogen and a gestagen
10/09/1996EP0735882A1 Combination contraceptive containing progesterone antagonists and a progestogen
10/09/1996EP0735881A1 Means and method for hormonal contraception and/or the treatment of acne
10/09/1996EP0735880A1 Use of vanadium molybdenum or tungsten complexes for controlling cellular proliferation
10/09/1996EP0735879A1 Use of amino cyclodextrins for the aqueous solubilisation of dibenzazepines for use as an antiepileptic agent.
10/09/1996EP0735878A1 Pharmaceuticals
10/09/1996EP0735877A1 6-(2-imidazolinylamino)quinoxaline compounds useful as alpha-2 adrenoceptor agonists
10/09/1996EP0735876A1 Lactone stable formulation of 10-hydroxy 7-ethyl camptothecin
10/09/1996EP0735875A1 Use of thalidomide for the treatment of non-insulin dependent diabetes mellitus
10/09/1996EP0735874A1 Use of thalidomide for treating neurocognitive disorders
10/09/1996EP0735873A1 Use of pyridone derivatives as anesthetic drugs
10/09/1996EP0735872A1 A method of treating neurogenic inflammation
10/09/1996EP0735871A1 Pharmaceutical compositions containing ceftriaxone and penems
10/09/1996EP0735870A1 Use of pla 2? inhibitors as treatment for alzheimer's disease
10/09/1996EP0735869A1 A method of treating gastrointestinal motility disorders
10/09/1996EP0735868A1 Use of non-steroidal cyclooxygenase inhibitors to treat elevated intraocular pressure
10/09/1996EP0735867A1 Transdermal delivery device containing an estrogen
10/09/1996EP0735864A1 Method for preparing low dose pharmaceutical products
10/09/1996EP0735863A1 Accelerated release composition containing bromocriptine
10/09/1996EP0735862A1 Method for dry blend compression of medicaments
10/09/1996EP0735861A1 Tissue moisturizing and antimicrobial compositions
10/09/1996EP0735821A1 Methods for the treatment or prevention of conditions associated with amyloidogenic reptides
10/09/1996EP0735819A1 New cryptophycins
10/09/1996EP0724648A4 Methods for screening antiestrogen compounds
10/09/1996EP0678089B1 N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders
10/09/1996EP0678088B1 N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders
10/09/1996EP0647227B1 Purinone antianginal agents
10/09/1996EP0640088B1 Novel tricyclic thiazolo and thiazino derivatives and anti-viral medicaments containing them
10/09/1996EP0637236B1 Pharmaceutical preparation and process for its manufacture
10/09/1996EP0635021B1 Process for producing derivatives of bis(aminomethyl) phosphinic acid
10/09/1996EP0609415B1 Nitric esters of derivatives of the 2-(2,6-di-halophenylamino)phenylacetic acid and process for their preparation
10/09/1996EP0594578B1 Oligoribonucleoside and oligodeoxyribonucleoside boranophosphates
10/09/1996EP0513351B1 2-nitroimidazole derivative, production thereof, and radiosensitizer containing the same as active ingredient
10/09/1996EP0457921B1 Novel platinum (ii) complex and drug for treating malignant tumor
10/09/1996EP0354921B1 Use of melatonin for the manufacture of a contraceptive composition
10/09/1996CN1133049A Melanona-inhibiting protein
10/09/1996CN1133045A 7-azabicyclo-|2,2,1¨-heptane and-heptene derivatives as analgesics and anti-inflammatory agents
10/09/1996CN1133044A Antipsychotic method
10/09/1996CN1133043A Bicyclic aromatic compounds as therapeutic agents
10/09/1996CN1133042A Indole derivatives as NMDA antagonists
10/09/1996CN1133041A New compound and its prep.
10/09/1996CN1133040A Benzothiophenes and related compounds as estrogen agonists
10/09/1996CN1133035A Substituted pyridine-2-ones and substituted pyridine-2-thiones as biocides
10/09/1996CN1133011A Preparation for substitution therapy containing at least one progestogen and at least one extrogen
10/09/1996CN1133010A Analgesic agent and its use
10/09/1996CN1133009A Levobupivacaine useful for managing chronic pain
10/09/1996CN1133008A Antipsychotic method
10/09/1996CN1133007A Di- and tetra-hydrobenzo|F¨ quinolin-3-ones
10/09/1996CN1133006A Pharmaceutical composition containing drug/beta-cyclodextrin complex in combination with acid-base couple
10/09/1996CN1133005A Stabilized tablet formulation
10/09/1996CN1133004A Process for conditioning substances
10/09/1996CN1132756A Antiviral ethers of aspartate protease substrate isosteres
10/09/1996CN1132755A Aescinic lactonic derivative, its prep. and medicine composition thereof
10/09/1996CN1132752A Beta-lactams derivative and its prep. and use
10/09/1996CN1132751A Novel sulfonamides compound and its use as medicine
10/09/1996CN1132750A Thiazolidine and oxazolidine derivatives, their preparation and their medical use
10/09/1996CN1132745A Substituted henzoylguanidines, process for their preparation, their use as medicament or diagnostic, and medicament containing them
10/09/1996CN1132637A Liniment and its prepn
10/09/1996CN1132626A Improved calcium dietary supplement
10/09/1996CN1132625A NK-1 receptor antagonits and 5HT3 receptor antagonists for treatment of emesis
10/09/1996CN1132607A Fortified fruit juices
10/09/1996CN1132591A Fungicidal active compound combinations
10/09/1996CN1032951C Tortoise and soft-shelled turtle composition and its prep.
10/08/1996US5563286 Elimination of 4-protected hydroxy group in presence of hydrogen radical source and a free radical initiator
10/08/1996US5563278 Angiotensin II antagonists
10/08/1996US5563272 5,6-dihydro-4H-imidazo[4,5,1-IJ]quinolines
10/08/1996US5563268 Heterobiaryl derivatives
10/08/1996US5563265 Bactericides
10/08/1996US5563258 Sucralfate aqueous suspension and its method of preparation
10/08/1996US5563255 Antisense oligonucleotide modulation of raf gene expression
10/08/1996US5563177 Taste masking guaifenesin containing liquids
10/08/1996US5563176 Illudin analogs useful as antitumor agents
10/08/1996US5563175 GABA and L-glutamic acid analogs for antiseizure treatment
10/08/1996US5563173 Anti-proliferative effects of sodium butyrate
10/08/1996US5563171 Using substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxole
10/08/1996US5563170 Antiischemic agents
10/08/1996US5563169 Inhibitors of acylcoenzyme a:cholesterol transferase, for treatment and/or prevention of atherosclerosis
10/08/1996US5563167 Administering to inhibit platelet aggregation
10/08/1996US5563165 Prostaglandin inhibitor; fda orange book listed patent for celebrex
10/08/1996US5563164 Treating arthritis, psoriasis, asthma, inflammatory bowel disease, or alzheimer's disease
10/08/1996US5563163 Treatment of degenerative diseases
10/08/1996US5563162 Bradykinin antagonist quinolines
10/08/1996US5563160 N-cyano-N'-pyridylguanidines as serotonin antagonists
10/08/1996US5563157 Excitatory amino acid antagonists
10/08/1996US5563154 Tetrahydro-quinolinyl/isoquinolinyl-terminal alkylamino ethynyl alanine amino diol compounds for treatment of hypertension